Home › NDC Lookup › RxCUI directory › RxCUI 863619

24 HR oxybutynin chloride 10 MG Extended Release Oral Tablet — RxCUI 863619

RxNorm drug concept · Semantic clinical drug
RxCUI 863619 Semantic clinical drug · SCD ● Current RxNorm concept 50 FDA products 120 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI863619
Official name24 HR oxybutynin chloride 10 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxyBUTYnin chloride 10 MG 24HR Extended Release Oral Tablet
FDA products mapped50
Package NDCs mapped120
Reported Medicaid activity (SDUD)596,096 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxybutynin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The patch works by calming the bladder muscle so it doesn't squeeze unexpectedly. That helps reduce the sudden urge to rush to the bathroom, how often you need to go, and accidenta...
  • What exactly does this patch do — and how long before I notice a difference?
  • You can wear the patch on your abdomen, hip, or buttocks — whichever is most comfortable and easiest to keep covered by clothing. Apply it to clean, dry skin with no lotions, oils,...
  • Where do I put the patch, and how often do I change it?
📖 Read our full Oxybutynin Transdermal Patch guide →

🕸️ Concept Web — How 24 HR oxybutynin chloride 10 MG Extended Release... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR oxybutynin chloride 10 MG Extended Release Oral Tablet RxCUI 863619

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Oxybutynin 32675
    • Oxybutynin chloride 54251
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxybutynin Extended Release Oral Tablet 373194
    • Oxybutynin chloride Extended Release Oral Tablet 2648583
    • Oxybutynin Oral Product 1160155
    • Oxybutynin Pill 1160156
    • Oxybutynin chloride Oral Product 2659390
    • Oxybutynin chloride Pill 2662465
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Oxybutynin chloride 10 MG 863618

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxybutynin chloride 10 MG SCDC · 863618
  • Oxybutynin Extended Release Oral Tablet SCDF · 373194
  • Oxybutynin chloride Extended Release Oral Tablet SCDFP · 2648583
  • Oxybutynin Oral Product SCDG · 1160155
  • Oxybutynin Pill SCDG · 1160156
  • Oxybutynin chloride Oral Product SCDGP · 2659390
  • Oxybutynin chloride Pill SCDGP · 2662465

📦 FDA Products & Package NDCs

50 products · 120 package NDCs
120 package NDCs map to RxCUI 863619 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00615-8220-39 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (... oxybutynin NCS HealthCare of KY, LLC dba Vangard Labs 2018-06-28
16729-0317-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-01) oxybutynin chloride Accord Healthcare, Inc. 2016-12-14
16729-0317-16 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-16) oxybutynin chloride Accord Healthcare, Inc. 2017-03-30
16729-0318-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-318-01) oxybutynin chloride Accord Healthcare, Inc. 2016-12-20
16729-0318-16 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-318-16) oxybutynin chloride Accord Healthcare, Inc. 2017-04-17
16729-0319-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-319-01) oxybutynin chloride Accord Healthcare, Inc. 2016-12-14
27241-0155-04 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-155-04) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
27241-0155-08 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-155-08) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
27241-0156-04 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-156-04) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
27241-0156-08 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-156-08) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
27241-0157-04 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-157-04) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
27241-0157-08 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-157-08) Oxybutynin Chloride Ajanta Pharma USA Inc. 2019-02-28
42291-0633-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-633-01) Oxybutynin Chloride Extended Release AvKARE 2016-03-09
42291-0633-50 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-633-50) Oxybutynin Chloride Extended Release AvKARE 2016-03-09
42291-0634-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-634-01) Oxybutynin Chloride Extended Release AvKARE 2016-03-09
42291-0634-50 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-634-50) Oxybutynin Chloride Extended Release AvKARE 2016-03-09
42291-0635-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-635-01) Oxybutynin Chloride Extended Release AvKARE 2016-03-09
43063-0790-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-790-... Oxybutynin Chloride Extended Release PD-Rx Pharmaceuticals, Inc. 2017-09-21
43353-0282-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-30) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-03-02
43353-0282-53 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-53) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-03-02
43353-0282-60 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-60) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-03-02
43353-0282-80 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-80) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2023-05-31
43353-0284-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-284-30) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-10-19
43353-0284-60 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-284-60) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-10-19
43353-0322-16 6000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-322-16) Oxybutynin Chloride Extended Release Aphena Pharma Solutions - Tennessee, LLC 2017-05-11
50090-4307-00 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4307-0) oxybutynin chloride A-S Medication Solutions 2019-05-23
50090-5353-00 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-... oxybutynin A-S Medication Solutions 2020-11-11
50090-6673-00 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6673-0) Oxybutynin Chloride Extended Release A-S Medication Solutions 2023-09-01
50268-0627-15 50 BLISTER PACK in 1 BOX (50268-627-15) / 1 TABLET, EXTENDE... Oxybutynin Chloride Extended Release AvPAK 2012-05-25
50268-0628-15 50 BLISTER PACK in 1 BOX (50268-628-15) / 1 TABLET, EXTENDE... Oxybutynin Chloride Extended Release AvPAK 2012-05-25
50268-0629-13 30 BLISTER PACK in 1 BOX (50268-629-13) / 1 TABLET, EXTENDE... Oxybutynin Chloride Extended Release AvPAK 2012-05-25
62135-0507-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-507-90) oxybutynin chloride Chartwell RX, LLC 2023-03-03
62135-0508-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-508-90) oxybutynin chloride Chartwell RX, LLC 2023-03-03
62135-0509-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-509-90) oxybutynin chloride Chartwell RX, LLC 2023-03-03
62175-0270-37 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
62175-0270-41 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
62175-0271-37 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-271-37) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
62175-0271-41 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-271-41) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
62175-0272-37 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-272-37) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
62175-0272-41 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-272-41) Oxybutynin Chloride Extended Release Lannett Company, Inc. 2009-03-01
64980-0209-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-01) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2016-09-27
64980-0209-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-03) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2022-03-29
64980-0209-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-05) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2022-03-29
64980-0210-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-210-01) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2016-09-27
64980-0210-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-210-05) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2022-03-29
64980-0211-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-211-01) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2016-09-27
64980-0211-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-211-05) Oxybutynin Chloride Extended Release Rising Pharma Holdings, Inc. 2022-03-29
65162-0371-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-03) Oxybutynin Chloride Amneal Pharmaceuticals LLC 2015-11-02
65162-0371-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-09) Oxybutynin Chloride Amneal Pharmaceuticals LLC 2015-11-02
65162-0371-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-371-10) Oxybutynin Chloride Amneal Pharmaceuticals LLC 2015-11-02
Observed labelers: Zydus Lifesciences Limited (18) · Zydus Pharmaceuticals USA Inc. (18) · Amneal Pharmaceuticals LLC (13) · Bryant Ranch Prepack (8) · Aphena Pharma Solutions - Tennessee, LLC (7) · Rising Pharma Holdings, Inc. (7) · +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.